WHAT WE DO —

WHO

ARE WE ?

Vaxxium’s mission is to provide biotech companies with a global solution to conduct pre-clinical and early Phase I to III clinical studies for potential candidate vaccines and biological products.

OUR TEAM
— WHAT WE DO —

OUR MISSION

In the past decades vaccinology has become a science on its own at the frontiers of microbiology, immunology and biotechnology. The CEVAC Team conducted numerous (>25) Phase I and I/II studies evaluating candidate vaccines using novel antigens, delivery systems and adjuvants.

VAXXIUM Immunology Lab performed immunomonitoring assays for numerous (>20) Phase I and I/II clinical trials evaluating candidate vaccines that we conducted in the lab or elsewhere.

— WHY US —

OUR ADVANTAGES

— TIMELINES FOR SUBMISSION

— HIGH AND FAST RECRUITMENT RATE

— A SMALL COUNTRY WITH A VERY HIGH DENSITY OUTSTANDING FACILITIES, SKILLS AND COMPETENCES

— COMPETITIVE PRICES - LESS EXPENSIVE THAN MANY OTHER EUROPEAN COUNTRIES

<
STAY IN TOUCH
contact us